Explore

Rapid Read Rapid Read
Michael and Susan Dell Donate $750 Million to Establish AI-Native Medical Center at University of Texas

Michael and Susan Dell Donate $750 Million to Establish AI-Native Medical Center at University of Texas

Michael and Susan Dell have announced a $750 million donation to the University of Texas at Austin to establish an 'AI-native' medical center. This significant contribution aims to enhance patient care through the integration of artificial intelligence and expand healthcare options in Austin, Texas. The UT Dell Medical Center, expected to open in 2030, will be part of a new 300-acre advanced research campus. This donation marks the Dells as the first donors to contribute over $1 billion to the University of Texas, building on their long-standing support for education and healthcare. The center will collaborate with the University of Texas MD Anderson Cancer Center to provide specialized care for complex conditions. The initiative is designed to integrate AI from the ground up, making the hospital an 'intelligent member of the care team' to improve patient-doctor interactions and healthcare outcomes.
Rapid Read Rapid Read
Michael and Susan Dell Pledge $750 Million to Establish Life Sciences Hub at University of Texas

Michael and Susan Dell Pledge $750 Million to Establish Life Sciences Hub at University of Texas

Michael and Susan Dell have announced a significant philanthropic contribution of $750 million to the University of Texas at Austin, aimed at establishing the UT Dell Campus for Advanced Research and the UT Dell Medical Center. This donation, one of the largest announced this year, will support various initiatives including undergraduate scholarships, student housing, and the university’s Advanced Computing Center. The new campus will integrate research programs with computing capabilities and clinical care, featuring a medical center designed to incorporate technology, data, and artificial intelligence into patient care. The University of Texas MD Anderson Cancer Center will collaborate with the Dell Medical Center to provide cancer care. The medical center is expected to open in 2030.
AP News AP News
Michael and Susan Dell fund 'AI-native' medical center with $750 million gift to University of Texas

Michael and Susan Dell fund 'AI-native' medical center with $750 million gift to University of Texas

Billionaires Michael and Susan Dell are donating $750 million to the University of Texas at Austin
Rapid Read Rapid Read
Michael Dell Pledges $750 Million for New Medical Facility and Research Center in Austin

Michael Dell Pledges $750 Million for New Medical Facility and Research Center in Austin

Michael Dell, founder of Dell Technologies, and his wife Susan have announced a $750 million donation to the University of Texas in Austin. This substantial contribution will fund the establishment of the UT Dell Campus for Advanced Research and the UT Dell Medical Center. The new medical facility, set to open in 2030, will include a cancer center in collaboration with MD Anderson in Houston. The initiative aims to integrate data, computing, and artificial intelligence to enhance medical decision-making and patient outcomes. This donation is part of Dell's ongoing support for the university, where he has previously contributed over $1 billion.
Trendline Trendline
AcuityMD Secures $80M to Enhance MedTech Sales with Agentic AI

AcuityMD Secures $80M to Enhance MedTech Sales with Agentic AI

AcuityMD Secures $80M to Enhance MedTech Sales with Agentic AI
Rapid Read Rapid Read
Atropos Health Launches Alexandria, Revolutionizing Medical Evidence Access for U.S. Physicians

Atropos Health Launches Alexandria, Revolutionizing Medical Evidence Access for U.S. Physicians

Atropos Health has launched Alexandria, the world's largest library of precision Real-World Evidence (pRWE), designed to provide evidence-based answers to complex medical questions. The library currently contains over 33 million artifacts and is expected to grow to two billion by the end of 2026. Alexandria integrates directly into existing clinical workflows, reaching about one-third of U.S. physicians and half of the major U.S. health systems. The platform's AI solution has outperformed major foundational models in providing accurate, evidence-based answers to clinician questions. This integration aims to close the evidence gap at the point of care, enhancing the ability of healthcare providers to make informed decisions.
Trendline Trendline
ECRI Spins Off Healthcare Supply Chain Division to Form Staritas

ECRI Spins Off Healthcare Supply Chain Division to Form Staritas

ECRI Spins Off Healthcare Supply Chain Division to Form Staritas
Trendline Trendline
Nanostics Validates ClarityDX Prostate Models for Improved Cancer Prediction

Nanostics Validates ClarityDX Prostate Models for Improved Cancer Prediction

Nanostics Validates ClarityDX Prostate Models for Improved Cancer Prediction
Rapid Read Rapid Read
Nature Conference Explores Precision Medicine's Transition from Innovation to Implementation

Nature Conference Explores Precision Medicine's Transition from Innovation to Implementation

The 'Reframing Precision Medicine: Innovation to Implementation' conference, organized by Nature, is set to take place in London. This event aims to bridge the gap between the theoretical advancements in precision medicine and their practical application in healthcare. The conference will focus on how multi-omics, artificial intelligence, and big data are transforming diagnosis and treatment. It will feature global leaders in science, medicine, and policy, discussing the integration of these technologies into clinical practice. The event will also offer training sessions and opportunities for attendees to engage with experts in the field.
Trendline Trendline
ModMed Acquires Bonsai Health to Enhance AI-Driven Patient Engagement

ModMed Acquires Bonsai Health to Enhance AI-Driven Patient Engagement

ModMed Acquires Bonsai Health to Enhance AI-Driven Patient Engagement
Trendline Trendline
Oracle Health Partners with CLEAR to Enhance Digital Patient Intake Process

Oracle Health Partners with CLEAR to Enhance Digital Patient Intake Process

Oracle Health Partners with CLEAR to Enhance Digital Patient Intake Process
Rapid Read Rapid Read
University of Pennsylvania Researchers Identify Underreported Side Effects of Weight-Loss Drugs Using AI

University of Pennsylvania Researchers Identify Underreported Side Effects of Weight-Loss Drugs Using AI

Researchers at the University of Pennsylvania have utilized artificial intelligence to analyze over 400,000 Reddit posts, uncovering potential side effects of GLP-1 drugs, such as semaglutide and tirzepatide, which are commonly used for weight loss and diabetes management. The study, published in Nature Health, highlights symptoms that may not be fully documented in clinical trials, including reproductive issues like irregular menstrual cycles and temperature-related effects such as chills and hot flashes. The research points to the value of social media in providing early insights into drug safety, as patients share experiences that may not be captured in traditional clinical settings.